Literature DB >> 16545779

Nanosecond pulsed electric fields cause melanomas to self-destruct.

Richard Nuccitelli1, Uwe Pliquett, Xinhua Chen, Wentia Ford, R James Swanson, Stephen J Beebe, Juergen F Kolb, Karl H Schoenbach.   

Abstract

We have discovered a new, drug-free therapy for treating solid skin tumors. Pulsed electric fields greater than 20 kV/cm with rise times of 30 ns and durations of 300 ns penetrate into the interior of tumor cells and cause tumor cell nuclei to rapidly shrink and tumor blood flow to stop. Melanomas shrink by 90% within two weeks following a cumulative field exposure time of 120 micros. A second treatment at this time can result in complete remission. This new technique provides a highly localized targeting of tumor cells with only minor effects on overlying skin. Each pulse deposits 0.2 J and 100 pulses increase the temperature of the treated region by only 3 degrees C, ten degrees lower than the minimum temperature for hyperthermia effects.

Entities:  

Mesh:

Year:  2006        PMID: 16545779      PMCID: PMC1513546          DOI: 10.1016/j.bbrc.2006.02.181

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  22 in total

1.  Intracellular effect of ultrashort electrical pulses.

Authors:  K H Schoenbach; S J Beebe; E S Buescher
Journal:  Bioelectromagnetics       Date:  2001-09       Impact factor: 2.010

2.  Radiofrequency ablation: the experts weigh in.

Authors:  Kenneth K Tanabe; Steven A Curley; Gerald D Dodd; Allan E Siperstein; S Nahum Goldberg
Journal:  Cancer       Date:  2004-02-01       Impact factor: 6.860

3.  Nanosecond, high-intensity pulsed electric fields induce apoptosis in human cells.

Authors:  Stephen J Beebe; Paula M Fox; Laura J Rec; E Lauren K Willis; Karl H Schoenbach
Journal:  FASEB J       Date:  2003-06-17       Impact factor: 5.191

4.  Nanosecond pulsed electric field generators for the study of subcellular effects.

Authors:  Juergen F Kolb; Susumu Kono; Karl H Schoenbach
Journal:  Bioelectromagnetics       Date:  2006-04       Impact factor: 2.010

5.  IL-12 gene therapy using an electrically mediated nonviral approach reduces metastatic growth of melanoma.

Authors:  M Lee Lucas; Richard Heller
Journal:  DNA Cell Biol       Date:  2003-12       Impact factor: 3.311

6.  Diverse effects of nanosecond pulsed electric fields on cells and tissues.

Authors:  Stephen J Beebe; Jody White; Peter F Blackmore; Yuping Deng; Kenneth Somers; Karl H Schoenbach
Journal:  DNA Cell Biol       Date:  2003-12       Impact factor: 3.311

Review 7.  Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation.

Authors:  Anita Gothelf; Lluis M Mir; Julie Gehl
Journal:  Cancer Treat Rev       Date:  2003-10       Impact factor: 12.111

8.  Leukemic cell intracellular responses to nanosecond electric fields.

Authors:  Nianyong Chen; Karl H Schoenbach; Juergen F Kolb; R James Swanson; Allen L Garner; Jing Yang; Ravindra P Joshi; Stephen J Beebe
Journal:  Biochem Biophys Res Commun       Date:  2004-04-30       Impact factor: 3.575

9.  Differential effects in cells exposed to ultra-short, high intensity electric fields: cell survival, DNA damage, and cell cycle analysis.

Authors:  M Stacey; J Stickley; P Fox; V Statler; K Schoenbach; S J Beebe; S Buescher
Journal:  Mutat Res       Date:  2003-12-09       Impact factor: 2.433

10.  Calcium bursts induced by nanosecond electric pulses.

Authors:  P Thomas Vernier; Yinghua Sun; Laura Marcu; Sarah Salemi; Cheryl M Craft; Martin A Gundersen
Journal:  Biochem Biophys Res Commun       Date:  2003-10-17       Impact factor: 3.575

View more
  90 in total

1.  Non-thermal nanoelectroablation of UV-induced murine melanomas stimulates an immune response.

Authors:  Richard Nuccitelli; Kevin Tran; Kaying Lui; Joanne Huynh; Brian Athos; Mark Kreis; Pamela Nuccitelli; Edward C De Fabo
Journal:  Pigment Cell Melanoma Res       Date:  2012-09       Impact factor: 4.693

2.  Analysis of cell membrane permeabilization mechanics and pore shape due to ultrashort electrical pulsing.

Authors:  Ravindra P Joshi; Qin Hu
Journal:  Med Biol Eng Comput       Date:  2010-07-16       Impact factor: 2.602

3.  Electroporation-based technologies and treatments.

Authors:  Damijan Miklavcic; Lluis M Mir; P Thomas Vernier
Journal:  J Membr Biol       Date:  2010-07       Impact factor: 1.843

4.  The current-voltage relation for electropores with conductivity gradients.

Authors:  Jianbo Li; Hao Lin
Journal:  Biomicrofluidics       Date:  2010-03-01       Impact factor: 2.800

5.  Mechanisms for the intracellular manipulation of organelles by conventional electroporation.

Authors:  Axel T Esser; Kyle C Smith; T R Gowrishankar; Zlatko Vasilkoski; James C Weaver
Journal:  Biophys J       Date:  2010-06-02       Impact factor: 4.033

6.  Modified Blumlein pulse-forming networks for bioelectrical applications.

Authors:  Stefania Romeo; Maurizio Sarti; Maria Rosaria Scarfì; Luigi Zeni
Journal:  J Membr Biol       Date:  2010-07-07       Impact factor: 1.843

7.  Nanoelectroablation therapy for murine basal cell carcinoma.

Authors:  Richard Nuccitelli; Saleh Sheikh; Kevin Tran; Brian Athos; Mark Kreis; Pamela Nuccitelli; Kris S Chang; Ervin H Epstein; Jean Y Tang
Journal:  Biochem Biophys Res Commun       Date:  2012-07-04       Impact factor: 3.575

8.  Transmembrane molecular transport during versus after extremely large, nanosecond electric pulses.

Authors:  Kyle C Smith; James C Weaver
Journal:  Biochem Biophys Res Commun       Date:  2011-07-02       Impact factor: 3.575

9.  Quantification of electroporative uptake kinetics and electric field heterogeneity effects in cells.

Authors:  S M Kennedy; Z Ji; J C Hedstrom; J H Booske; S C Hagness
Journal:  Biophys J       Date:  2008-03-13       Impact factor: 4.033

10.  Active mechanisms are needed to describe cell responses to submicrosecond, megavolt-per-meter pulses: cell models for ultrashort pulses.

Authors:  Kyle C Smith; James C Weaver
Journal:  Biophys J       Date:  2008-04-11       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.